Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Whole genome analysis plays a critical role in the development of life-saving diagnostics, therapeutics, and vaccines, with growing interest in noncoding regions and Whole genome analysis plays a ...

Next-generation sequencing (NGS) has moved away from expensive runs and complicated workflows into a new era where benchtop instruments prioritize sustainability, accessibility, accuracy, and speed.

The field of genetic epidemiology has been revolutionized by recent advancements in next-generation sequencing technologies, as well as the development of ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...